Published in Adv Drug Deliv Rev on October 31, 2000
Nonviral delivery of synthetic siRNAs in vivo. J Clin Invest (2007) 2.78
DNA-based therapeutics and DNA delivery systems: a comprehensive review. AAPS J (2005) 2.03
Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs. Nucleic Acids Res (2001) 1.67
Progress in microRNA delivery. J Control Release (2013) 1.58
Nano-vectors for efficient liver specific gene transfer. Int J Nanomedicine (2008) 1.11
Advances in antisense oligonucleotide development for target identification, validation, and as novel therapeutics. Gene Regul Syst Bio (2008) 1.05
Gene modulation for treating liver fibrosis. Crit Rev Ther Drug Carrier Syst (2007) 0.99
Selective enhancement of nucleases by polyvalent DNA-functionalized gold nanoparticles. J Am Chem Soc (2011) 0.99
Nuclease-resistant DNA via high-density packing in polymeric micellar nanoparticle coronas. ACS Nano (2013) 0.93
Antitumor activity of G3139 lipid nanoparticles (LNPs). Mol Pharm (2009) 0.88
Nanotechnology and the treatment of HIV infection. Viruses (2012) 0.84
Poly(alkylene oxide) copolymers for nucleic acid delivery. Acc Chem Res (2012) 0.84
Delivery of large biopharmaceuticals from cardiovascular stents: a review. Biomacromolecules (2007) 0.83
Probing the in vitro mechanism of action of cationic lipid/DNA lipoplexes at a nanometric scale. Nucleic Acids Res (2010) 0.80
Functional polymers of gene delivery for treatment of myocardial infarct. J Control Release (2014) 0.80
Glycotargeting to improve cellular delivery efficiency of nucleic acids. Glycoconj J (2007) 0.79
Combined effects of Cantide and chemotherapeutic drugs on inhibition of tumor cells' growth in vitro and in vivo. World J Gastroenterol (2005) 0.79
Inhibition of human telomerase reverse transcriptase in vivo and in vitro for retroviral vector-based antisense oligonucleotide therapy in ovarian cancer. Cancer Gene Ther (2016) 0.78
Influence of dimethylsulfoxide on RNA structure and ligand binding. Anal Chem (2013) 0.78
An activated triple bond linker enables 'click' attachment of peptides to oligonucleotides on solid support. Nucleic Acids Res (2011) 0.75
Improved hybridisation potential of oligonucleotides comprising O-methylated anhydrohexitol nucleoside congeners. Nucleic Acids Res (2001) 0.75
DNA as therapeutics; an update. Indian J Pharm Sci (2009) 0.75
Barriers to Liposomal Gene Delivery: from Application Site to the Target. Iran J Pharm Res (2016) 0.75
In vitro detection of mdr1 mRNA in murine leukemia cells with 111In-labeled oligonucleotide. Eur J Nucl Med Mol Imaging (2004) 0.75
A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med (1997) 17.51
The Biomolecular Interaction Network Database and related tools 2005 update. Nucleic Acids Res (2005) 12.94
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group. J Clin Oncol (1999) 9.22
Statistical problems in the reporting of clinical trials. A survey of three medical journals. N Engl J Med (1987) 8.64
A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team. N Engl J Med (1996) 7.60
Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med (2010) 6.38
Evidence for autolysin-mediated primary attachment of Staphylococcus epidermidis to a polystyrene surface. Mol Microbiol (1997) 5.47
The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team. N Engl J Med (1996) 4.03
Cloning and sequencing of the metallothioprotein beta-lactamase II gene of Bacillus cereus 569/H in Escherichia coli. J Bacteriol (1985) 3.95
European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol (2009) 3.56
Polarity of T cell shape, motility, and sensitivity to antigen. Immunity (1996) 3.33
A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group. N Engl J Med (1992) 3.13
Surveillance of endophthalmitis following cataract surgery in the UK. Eye (Lond) (2004) 3.07
Accumulation of glyceride-containing precursor of the outer membrane lipoprotein in the cytoplasmic membrane of Escherichia coli treated with globomycin. J Biol Chem (1980) 2.91
The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med (2002) 2.78
Optimal frequency of changing intravenous administration sets: is it safe to prolong use beyond 72 hours? Infect Control Hosp Epidemiol (2001) 2.74
Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis. Int J Tuberc Lung Dis (2007) 2.68
Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium. Lancet (1999) 2.62
Child abuse referral warning. Br Dent J (2006) 2.44
Meta-analysis for the evaluation of potential surrogate markers. Stat Med (1997) 2.22
Dose-finding designs for HIV studies. Biometrics (2001) 2.22
Molecular evolution and phylogeny of elapid snake venom three-finger toxins. J Mol Evol (2003) 2.14
Heterologously expressed Staphylococcus aureus fibronectin-binding proteins are sufficient for invasion of host cells. Infect Immun (2000) 2.11
Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Emergency control and prevention of early variceal rebleeding. Gastroenterology (1990) 2.02
Shipment of human islets for transplantation. Am J Transplant (2007) 2.01
Child abuse referral warning. Br Dent J (2006) 2.01
Estimation issues in clinical trials and overviews. Stat Med (1990) 2.01
Impaired action knowledge in amyotrophic lateral sclerosis. Neurology (2008) 1.97
Sphincter-sparing treatment for distal rectal adenocarcinoma. Ann Surg Oncol (1999) 1.95
Characterization of new membrane lipoproteins and their precursors of Escherichia coli. J Biol Chem (1981) 1.94
Religious circumcision: a Muslim view. BJU Int (1999) 1.93
Mortality in a large tuberculosis treatment trial: modifiable and non-modifiable risk factors. Int J Tuberc Lung Dis (2006) 1.91
Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia (2006) 1.90
Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group. Am Rev Respir Dis (1992) 1.89
Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate. Oncogene (2010) 1.87
P504S: a new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol (2001) 1.86
Sexual dimorphism in plasma leptin concentration. J Clin Endocrinol Metab (1997) 1.85
Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion. Hepatology (1999) 1.80
Construction and applications of DNA probes for detection of polychlorinated biphenyl-degrading genotypes in toxic organic-contaminated soil environments. Appl Environ Microbiol (1990) 1.80
L-asparaginase therapy for leukemia and other malignant neoplasms. Remission in human leukemia. JAMA (1967) 1.78
Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen. J Immunol (1994) 1.77
Does adjunctive midazolam reduce recovery agitation after ketamine sedation for pediatric procedures? A randomized, double-blind, placebo-controlled trial. Ann Emerg Med (2000) 1.76
Bacillus cereus 569/H beta-lactamase I: cloning in Escherichia coli and signal sequence determination. FEBS Lett (1983) 1.75
Discitis in young children. J Bone Joint Surg Br (2001) 1.72
Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong. Hepatology (2000) 1.69
Diurnal and ultradian rhythmicity of plasma leptin: effects of gender and adiposity. J Clin Endocrinol Metab (1998) 1.68
The care of older persons with diabetes mellitus: families and primary care physicians. J Am Geriatr Soc (1996) 1.67
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Control of axillary bud initiation and shoot architecture in Arabidopsis through the SUPERSHOOT gene. Genes Dev (2001) 1.66
The effect of diet on ileostomy function. Gut (1970) 1.65
Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids. J Clin Invest (1997) 1.63
Follicular variant of papillary thyroid carcinoma: a comparative study of histopathologic features and cytology results in 141 patients. Endocr Pract (2001) 1.63
Anticancer drug response and expression of molecular markers in early-passage xenotransplanted colon carcinomas. Eur J Cancer (2004) 1.61
Mechanism of signal peptide cleavage in the biosynthesis of the major lipoprotein of the Escherichia coli outer membrane. J Biol Chem (1982) 1.59
Desquamative gingivitis: retrospective analysis of disease associations of a large cohort. Oral Dis (2008) 1.59
Prognostic factors in patients with surgically resected stages I and II non-small cell lung cancer. Ann Thorac Surg (2000) 1.58
Fournier's gangrene and its emergency management. Postgrad Med J (2006) 1.56
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Phase II evaluation of oral estramustine and oral etoposide in hormone-refractory adenocarcinoma of the prostate. J Clin Oncol (1994) 1.56
Evolution of hepatitis B virus polymerase gene mutations in hepatitis B e antigen-negative patients receiving lamivudine therapy. Hepatology (2000) 1.55
Catheter-related infections caused by the Mycobacterium fortuitum complex: 15 cases and review. Rev Infect Dis (1992) 1.54
Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet (2001) 1.54
Care-seeking practices in South Asia: using formative research to design program interventions to save newborn lives. J Perinatol (2008) 1.52
A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection. Ann Oncol (2011) 1.51
Abnormal insulin secretion and glucose metabolism in pancreatic islets from the spontaneously diabetic GK rat. Diabetologia (1993) 1.51
Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris. J Am Coll Cardiol (1993) 1.51
Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus. Hepatology (1995) 1.50
Measurement of the depth of maximum of extensive air showers above 10{18} eV. Phys Rev Lett (2010) 1.48
Front-line management of pulmonary tuberculosis: an analysis of tuberculosis and treatment practices in urban Sindh, Pakistan. Tuber Lung Dis (1996) 1.48
Spinal epidural cavernous angioma presenting as a lumbar radiculopathy with analysis of magnetic resonance imaging characteristics: case report. Neurosurgery (1995) 1.47
Determination of the pKa and pH-solubility behavior of an ionizable cyclic carbamate, (S)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4- (trifluoromethyl)-2H-3,1-benzoxazin-2-one (DMP 266). Pharm Dev Technol (1996) 1.47
Practical problems in interim analyses, with particular regard to estimation. Control Clin Trials (1989) 1.46
Differences between women and men in adverse events and CD4+ responses to nucleoside analogue therapy for HIV infection. The Aids Clinical Trials Group 175 Team. J Acquir Immune Defic Syndr (2000) 1.45
Mouse mammary tumor virus-like ENV gene sequences in human breast tumors and in a lymphoma of a breast cancer patient. Clin Cancer Res (2000) 1.45
Vibrio cholerae O139 in Calcutta, 1992-1998: incidence, antibiograms, and genotypes. Emerg Infect Dis (2000) 1.45
Variable pathologic interpretation of columnar lined esophagus by general pathologists in community practice. Gastrointest Endosc (1999) 1.45
Searches for Lepton flavor violation in the decays tau{+/-}-->e{+/-}gamma and tau{+/-}-->mu{+/-}gamma. Phys Rev Lett (2010) 1.44
A comparison of two dosing regimens of zidovudine in Thai adults with early symptomatic HIV infection. Conducting clinical HIV trials in South-East Asia. Aust N Z J Med (2000) 1.42
Serum immunoreactive trypsin in beta-thalassaemia major. J Clin Pathol (1981) 1.41
Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B. J Lipid Res (1999) 1.40
Giant gastric ulceration associated with antiphospholipid antibody syndrome. Am J Gastroenterol (1996) 1.40
Taxanes: an overview of the pharmacokinetics and pharmacodynamics. Urology (1999) 1.39
Multiple dosing of ephedra-free dietary supplements: hemodynamic, electrocardiographic, and bacterial contamination effects. Clin Pharmacol Ther (2012) 1.39
Slime production and adherence by coagulase-negative staphylococci. J Hosp Infect (1991) 1.39
Chronic steroid dependent asthma and pulmonary function. N J Med (1991) 1.39
Psychotic and nonpsychotic depression: comparison of response to ECT. J Clin Psychiatry (1988) 1.39
Diagnosis and laparoscopic management of 12 consecutive cases of ovarian pregnancy and review of literature. J Minim Invasive Gynecol (2009) 1.39
Carbamazepine and SIADH. Am J Psychiatry (1989) 1.38
Synthesis and cytotoxicity of shikimate analogues. Structure:activity studies based on 1-crotonyloxymethyl-3R,4R,5R-trihydroxycyclohex-2-enone. Anticancer Drug Des (1992) 1.38
Excitation-contraction coupling in rat ventricular myocytes after formamide-induced detubulation. Am J Physiol (1999) 1.36
Antitumour activity of S-p-bromobenzylglutathione cyclopentyl diester in vitro and in vivo. Inhibition of glyoxalase I and induction of apoptosis. Biochem Pharmacol (1996) 1.36
Pediatric urolithiasis: developing nation perspectives. J Urol (2002) 1.36
Cloning and sequencing of the blaZ gene encoding beta-lactamase III, a lipoprotein of Bacillus cereus 569/H. J Bacteriol (1987) 1.34
Impact of protease inhibitor-containing combination antiretroviral therapies on height and weight growth in HIV-infected children. Pediatrics (2001) 1.33
Maternal and newborn-care practices during pregnancy, childbirth, and the postnatal period: a comparison in three rural districts in Bangladesh. J Health Popul Nutr (2006) 1.33
Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients. The National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators. Antimicrob Agents Chemother (1999) 1.32
Resistance of peripheral autonomic neurons to in vivo productive infection by herpes simplex virus mutants deficient in thymidine kinase activity. Infect Immun (1981) 1.32
Pyoverdin-facilitated iron uptake in Pseudomonas aeruginosa: immunological characterization of the ferripyoverdin receptor. Mol Microbiol (1990) 1.31
Racial disparity in incidence patterns and outcome of kidney cancer. Urology (2003) 1.30